• ქართული
  • English
  • Pfizer in talks to merge off-patent drugs business with Mylan -source

    Pfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a stock deal, according to a source familiar with the matter.

    Market Quotes by TradingView